CD8A and cervical carcinoma: On the contrary, neoadjuvant chemotherapy for cervical cancer resulted in a decreased FOXP3+ density, resulting in an elevated intratumoral CD8/FOXP3 ratio that might confer a favorable clinical outcome (26).